More specifically, evaluation of VEGF expression in gastrointestinal stromal tumor (GIST) using immunohistochemistry revealed that increased VEGF tumor expression was associated with inferior outcomes such as increased risk of liver metastases [25]. This evidence concerns the gene VEGFA and gastrointestinal stromal tumor.